Canaccord Genuity Raises Repligen Price Target to $180 From $145
Canaccord Genuity raised its price target on Repligen to $180 per share from $145.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.